A Smart Nasal Spray for the Safe At-Home Administration of Controlled Substances
Student Team: KnowSpray
KBLV Medical LLC
Around 16 million Americans suffer from depression and 5 million of them suffer from treatment resistant depression, meaning the standard medications don’t provide them relief. Ketamine is a drug that could help those with treatment resistant depression, but doctors are not comfortable sending patients home with it due to its abuse potential. Because of this, patients are required to go into the doctor’s office for many hours at a time in order to receive their treatment, which restricts this treatment to only patients with the necessary time, money, and access. We sought to create a method for doctors to feel comfortable sending patients home with their medication, which necessitates keeping them updated on patient compliance and health remotely. Our solution is therefore not merely a physical device, but a system to monitor and control substance administration at home, including a web server which communicates with a nasal spray device, patient mobile application, and an online portal and database for doctors. The device itself is a disposable internet-connected nasal spray which allows for the patient to take only the exact dose of medication on a schedule set by their doctor. Through a mobile application on the patient’s phone, users are notified of their dosage window and can track their own treatment with a log and calendar. The patient can also provide feedback to their physicians through the application, with the ability to report any side effects for the optimization of treatment. Through a secure online web application, doctors can easily track their patients’ compliance and feedback, as well as receive notifications should there be any problems such as severe side effects or device tampering.